NCT06574529View on ClinicalTrials.gov

Video-observed Therapy for Active Tuberculosis: a Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

November 26, 2021

Primary Completion Date

July 18, 2023

Study Completion Date

May 31, 2024

Conditions
Tuberculosis Active
Interventions
DEVICE

Video-observed therapy (vDOT)

All participants are required to send 5 times per week a short video showing they are actually taking their treatment for tuberculosis via a dedicated application on their cellphone

Trial Locations (1)

1205

Geneva University Hospital, Geneva

All Listed Sponsors
collaborator

University Hospital, Geneva

OTHER

lead

Ligue Pulmonaire Genevoise

OTHER

NCT06574529 - Video-observed Therapy for Active Tuberculosis: a Feasibility Study | Biotech Hunter | Biotech Hunter